These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 30243029)
21. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer. Luo F; Zhao Y; Liu J Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280 [TBL] [Abstract][Full Text] [Related]
22. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401 [TBL] [Abstract][Full Text] [Related]
23. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways. Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923 [TBL] [Abstract][Full Text] [Related]
24. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling. Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230 [TBL] [Abstract][Full Text] [Related]
25. Effects of Per2 overexpression on growth inhibition and metastasis, and on MTA1, nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in nude mice xenograft models of ovarian cancer. Wang Z; Li L; Wang Y Mol Med Rep; 2016 Jun; 13(6):4561-8. PubMed ID: 27082164 [TBL] [Abstract][Full Text] [Related]
26. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer. Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837 [TBL] [Abstract][Full Text] [Related]
27. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014 [TBL] [Abstract][Full Text] [Related]
28. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway. Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158 [TBL] [Abstract][Full Text] [Related]
29. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway. Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213 [TBL] [Abstract][Full Text] [Related]
30. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209 [TBL] [Abstract][Full Text] [Related]
32. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Whitley BR; Beaulieu LM; Carter JC; Church FC Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899 [TBL] [Abstract][Full Text] [Related]
33. RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway. Li Q; Li M; Wang YL; Fauzee NJ; Yang Y; Pan J; Yang L; Lazar A Cell Physiol Biochem; 2012; 29(3-4):361-72. PubMed ID: 22508044 [TBL] [Abstract][Full Text] [Related]
34. Estrogen stimulates the invasion of ovarian cancer cells via activation of the PI3K/AKT pathway and regulation of its downstream targets E‑cadherin and α‑actinin‑4. Lu Z; Zhang Y; Yan X; Chen Y; Tao X; Wang J; Jia N; Lyu T; Wang J; Ding J; Feng W; Hua K Mol Med Rep; 2014 Nov; 10(5):2433-40. PubMed ID: 25216292 [TBL] [Abstract][Full Text] [Related]
35. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
36. TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer. Hu C; Zhang R; Jiang D Arch Iran Med; 2019 Jan; 22(1):32-38. PubMed ID: 30821158 [TBL] [Abstract][Full Text] [Related]
37. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells. Li H; Zhou Y; Cheng H; Tian J; Yang S Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621 [TBL] [Abstract][Full Text] [Related]
38. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway. Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592 [TBL] [Abstract][Full Text] [Related]
39. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745 [TBL] [Abstract][Full Text] [Related]
40. Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement. Peng X; Zhou J; Li B; Zhang T; Zuo Y; Gu X Cancer Chemother Pharmacol; 2020 Feb; 85(2):309-320. PubMed ID: 31732769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]